UNSPSC 51144900: Stimulant or anorexiant carboxylic acids

This classification denotes organic compounds containing the carboxy group (-COOH), substances called carboxylic acids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term STIMULANT OR ANOREXIANT CARBOXYLIC ACIDS.

UNSPSC 51144900 Stimulant or anorexiant carboxylic acids is a Class code, but the recent state and local opportunities posted under it do not match its nominal scope. The three recent solicitations tracked under this code involve naloxone procurement for a Florida county health department, a Texas HHS direct-to-manufacturer prescription program, and a Minnesota multistate cooperative purchasing agreement for generic pharmaceuticals and OTC products — none of which are stimulant or anorexiant carboxylic acids. The mismatch suggests either a classification error in how these opportunities were tagged at the source or a broader use of this code to capture pharmaceutical procurement across multiple therapeutic categories and distribution models.

Issuing bodies include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), and a multistate cooperative purchasing alliance administered by a state procurement office (Minnesota Department of Administration). The geographic spread spans Florida, Texas, and Minnesota, with the MMCAP agreement extending to Oregon. Representative recent opportunities include Seminole County's IFB60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; Texas HHS's RFI HHS0017013 posted April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs; and Minnesota's MMCAP RFP S1070000015802, posted January 20, 2026, with a response deadline of March 26, 2026, for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The code shows little relevant activity under its stated pharmaceutical classification.